BRS Berlin Radiopharm Solutions
In vitro pharmacology, analytical development and regulatory affairs.
What they do
- Discovery & research
- Preclinical
- Development & CMC
- Regulatory & quality
From their website
Company website
- Target assessment and validation (opens in a new tab)
- In vivo pharmacology studies (opens in a new tab)
- Radiolabeling development (opens in a new tab)
- CDMO selection and management (opens in a new tab)
- Radiolabeling process development (opens in a new tab)
- Target and program assessment (opens in a new tab)
- CMC development strategy (opens in a new tab)
- Technical oversight (opens in a new tab)
- Radiochemical purity (opens in a new tab)
- Identity analysis (opens in a new tab)
- LogD analysis (opens in a new tab)
- Radiochemical stability (opens in a new tab)
- Competition assays (opens in a new tab)
- Internalization assays (opens in a new tab)
- Retention assays (opens in a new tab)
- Cytotoxicity assays (opens in a new tab)
- Cellular kinetics (opens in a new tab)
- Tissue-binding studies (opens in a new tab)
- Biodistribution studies (opens in a new tab)
- PK/PD studies (opens in a new tab)